News Focus
News Focus
Followers 26
Posts 5766
Boards Moderated 0
Alias Born 09/27/2005

Re: enemem post# 33881

Wednesday, 06/30/2010 7:11:44 PM

Wednesday, June 30, 2010 7:11:44 PM

Post# of 57993
enemem, I, and I'm sure others, find the e-mail discourses informative and instructive. If they're beneath the level of de rigueur you find worthy, you don't have to read them.

"I don't think you're doing us, yourself, or them any favors by emailing them like this." You don't have to read them.

"While you might think that you've asked questions that they could respond to, that's a matter of opinion, and I think they are right to err on the side of caution." You don't know that that's in fact what is happening. You don't have to read them.

"Notice that in his email, Varney did nothing more than reiterate almost word-for-word what was said at the SHM. He's not going to tell you something new, period. The exchanges with Varney are all vaiants on "are we there yet?"." You don't have to read them.

"What's bothersome to me isn't their silence, it's that when they volunteer information about timelines, this information has been wildly off." You don't have to read them.

But you do.

I found it interesting that MV updated us on the status of 2 ongoing trials -- "We are currently underway with stability studies for the drug product that will be used in the future ADHD study. After these studies are completed, we plan on filing an IND with the FDA requesting to proceed with the ADHD Ph 2 study. We are on target for this submission, as outlined at our ASM. The sleep apnea study continues. We are aiming for completion of this study around the end of the summer, again as outlined at our ASM." Previously he has informed me that there have been time slippages re past trials, so this is good news.

I found this interesting, too -- "We are continually looking at grant applications to help us with funding in certain therapeutic areas, as well as collaborations with academic groups to push forward the science. I will provide an update on the status of the above to shareholders at our next public presentation."

I didn't think I'd have to offer my interpretation of the exchange, but your post was disturbing.

"The deal with Biovail took 9 months of negotiations to complete..." Did we know this before?

I think it's progressive to make known the contents of these e-mails, even if some of it is reiteration.

Have a nice day.






Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today